Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995

M. Feldkamp; K. L. Jones; A. Ornoy; A. Pastuszak; S. Rosenbasser; B. Schick; J. Bar

doi:10.1001/jama.1997.03540390023011

Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995

M. Feldkamp, K. L. Jones, A. Ornoy, A. Pastuszak, S. Rosenbasser, B. Schick, J. Bar

Research output: Contribution to journal › Comment/debate

44 Scopus citations

Original language	English
Pages (from-to)	1193
Number of pages	1
Journal	JAMA - Journal of the American Medical Association
Volume	277
Issue number	15
DOIs	https://doi.org/10.1001/jama.1997.03540390023011
State	Published - 1997
Externally published	Yes

Access to Document

10.1001/jama.1997.03540390023011

Cite this

Feldkamp, M., Jones, K. L., Ornoy, A., Pastuszak, A., Rosenbasser, S., Schick, B., & Bar, J. (1997). Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995. JAMA - Journal of the American Medical Association, 277(15), 1193. https://doi.org/10.1001/jama.1997.03540390023011

@article{d3d6c1fe08144565a24c477611d90753,

title = "Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995",

author = "M. Feldkamp and Jones, {K. L.} and A. Ornoy and A. Pastuszak and S. Rosenbasser and B. Schick and J. Bar",

year = "1997",

doi = "10.1001/jama.1997.03540390023011",

language = "אנגלית",

volume = "277",

pages = "1193",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "15",

}

Feldkamp, M, Jones, KL, Ornoy, A, Pastuszak, A, Rosenbasser, S, Schick, B & Bar, J 1997, 'Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995', JAMA - Journal of the American Medical Association, vol. 277, no. 15, pp. 1193. https://doi.org/10.1001/jama.1997.03540390023011

TY - JOUR

T1 - Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995

AU - Feldkamp, M.

AU - Jones, K. L.

AU - Ornoy, A.

AU - Pastuszak, A.

AU - Rosenbasser, S.

AU - Schick, B.

AU - Bar, J.

PY - 1997

Y1 - 1997

UR - http://www.scopus.com/inward/record.url?scp=0030940523&partnerID=8YFLogxK

U2 - 10.1001/jama.1997.03540390023011

DO - 10.1001/jama.1997.03540390023011

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 9103332

AN - SCOPUS:0030940523

SN - 0098-7484

VL - 277

SP - 1193

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 15

ER -

Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995

Access to Document

Other files and links

Cite this